Variability in the rate of 6-mercaptopurine methylation in the erythrocytes, liver and kidney in an Italian population

European Journal of Clinical Pharmacology

Volumn 51, Issue 1, 1996, Pages 23-29

  Ferroni, M A ^a   Marchi, G ^a   Sansone, E ^b   Romeo, P ^b   Giulianotti, P C ^c   Pietrabissa, A ^a   Mosca, F ^a   Pacifici, G M ^a  

^a UNIVERSITY OF PISA   (Italy)

^b AOU of Pisa   (Italy)

^c Hospital of Pisa ^*

Author keywords

6 Mercaptopurine; Adults; Erythrocytes; Kidney; Liver; Newborns; Polymorphism; Thiopurine methyltransferase

Indexed keywords

MERCAPTOPURINE; THIOPURINE METHYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; HUMAN TISSUE; ITALY; KIDNEY; LIVER; MALE; METHYLATION; NEWBORN; PRIORITY JOURNAL;

6-MERCAPTOPURINE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ERYTHROCYTES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; ITALY; KIDNEY; LIVER; MALE; METHYLATION; METHYLTRANSFERASES; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 0029782591     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050155     Document Type: Article

References (37)

1. Anstey A, Lennard L, Mayou SC, Kirby JD (1992) Pancytopenia related to azathioprine: an enzyme deficiency caused by common genetic polymorphism: a review. J Roy Soc Med 85: 752-756
2. Calabresi P, Chabner AB (1992) Antineoplastic agents. In: Goodman A, Gilman A, Rall AW, Nies AS, Taylor P(eds). The pharmacological basis of therapy. 8th edn. McGraw-Hill. New York, pp 1209-1263
3. Chocair PR, Duley JA, Simmonds HA, Cameron JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53: 1051-1056
4. Evans DAP (1993) Methylation reaction. In: Evans DAP, Genetic factors in drug therapy (ed) Cambridge Universit Press, Cambridge, pp 330-345
5. Evans WE, Horner M, Chu YQ, Kalwinsky D, Roberts MW (1991) Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia. J Ped 119:985-989
6. Hale JP, Lilleyman JS (1991) Importance of 6-mercaptopurine dose in lymphoblastic leukaemia. Arch Dis Child 66:462-466
7. Hernandez JS, Van Loon JA, Otterness DM, Guerciolini R, Weinshilboum RM (1991) Thiopurine methyltransferase regulation in rat kidney: Immunoprecipitation studies. Xenobiotica 21:451-459
8. McLeod HL, Krynetsky EY, Wiliams JA, Evans WE (1995) Higher activity of polymorphic thiopurine S-methyltransferase in erythrocytes from neonates compared to adults. Pharmacogenetics 5:281-286
9. Jones CD, Smart C, Titus A, Blyden G, Dorvil M, Nwadike N (1993) Thiopurine methyltransferase activity in a sample population of black subjects in Florida. Clin Pharmacol Ther 53: 348-535
10. Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44: 147-152
11. Klemetsdal B, Tollefsen E, Loennechen T, Johnson K, Utsi E, Gisholt K, Wist E, Aarbakke J (1992) Interethnic difference in thiopurine methyltransferase activity. Clin Pharmacol Ther 51: 24-31
12. Klemetsdal B, Wist E, Aarbakke J (1993) Gender differences in red blood cell thiopurine methyltransferase activity. Scand J Clin Lab Invest 53:747-749
13. Krynetski EY, Schuetz JD, Galpin AJ, Pui CH, Relling MV, Evans WE (1995) A single point mutation leading to loss of catalytic activity in human thiopurine S-methyltransferase. Proc Natl Acad Sci USA 92:949-953
14. Lee EJD, Kalow W (1993) Thiopurine S-methyltransferase activity in a Chinese population. Clin Pharmacol Ther 54:28-33
15. Lennard L, Gibson BES, Nicole T, Lilleyman JS (1993) Congenital thiopurine methyltransferase deficiency and 6-mercaptopurine toxicity during treatment for acute lymphoblastic leukaemia. Arch Dis Child 69:577-579
16. Lennard F, Lilleyman JS, Van Loon J, Weinshilboum RW (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukaemia. Lancet 336:225-229
17. Lennard L, Van Loon J, Lilleyman, JS, Weinshilboum, RM (1987) Thiopurine pharmacogenetics in leukaemia: correlation of erythrocyte thiopurine methyltransferase activity and 6-thioguanine nucleotide concentrations. Clin Pharmacol Ther 41:18-25
18. Lowry OH, Rosebrough NJ, Farr A, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275
19. McLeod HF, Miller DR, Evans WE (1993) Azathioprine-indueed myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 341:1151
20. Pacifici GM, Fracchia GN (1995) Human methyltransferases. Classification and metabolic profile of the major forms. The point of view of the Clinical Pharmacologist. In: Pacifici GM, Fracchia GN. (eds). "Advances of drug metabolism in manCommission of the European Communities, Luxembourg, pp 461-493
21. Pacifici GM, Marchi G (1993) Interindividual variability of phenol- and catechol- sulphotransferase in platelets from adults and newborns. Br J Clin Pharmacol 36:593-597
22. Pacifici GM, Romiti P, Santerini S, Giuliani L (1993) S-methylation in human intestine: differential distribution of the microsomal thiol methyltransferase and cytosolic thiopurine methyltransferase along the human bowel. Xenobiotica 23: 671-679
23. Pacifici GM, Viani A, Franchi M, Gervasi PG, Longo V, Di Simplicio P, Temellini A, Romiti P, Santerini S, Vannucci L, Mosca F (1989) Profile of drug-metabolizing enzymes in the cortex and medulla of the human kidney. Pharmacology 39: 299-308
24. Pacifici GM, Romiti P, Giuliani L, Rane A (1991) Thiopurine Methyltransferase in humans: development and tissue distribution. Dev Pharmacol Ther 17:16-23
25. Powis G, Jardine I, Van Dyke R, Weinshilboum R, Moore D, Wilke T, Rhodes T, Nelson R, Benson L, Szumlanski C (1988) Foreign compound metabolism studies with human liver obtained as surgical waste. Drug Metab Disp 16:582-589
26. Reynolds EF (1993) Martindale. The extra pharmacopeia. 13th ed. Pharmaceutical Press, London, pp 486-488
27. Schwartz E, Gill FM (1983) Hematology of the newborn. In: Beutler E, Erslev AJ, Lichtman MA (eds) Williams WJ, Hematology, 3rd ed. McGraw-Hill New York, pp 37-47
28. Schutz E, Gummert J, Mohr F, Oellerich M (1993) Azathioprine-induced myelosuppression in thiopurine methyltransferase deficient heart transplant recipient. Lancet 341:436
29. Soria-Royer C, Legendre C, Mircheva J, Premel S, Beaune P, Kreis H (1993) Thiopurine-methyl-transferase activity to assess azathioprine myelotoxicity in renal transplant recipients. Lancet 341:1953-1954
30. Szumlanski CL, Scott MC, Weinshilboum RM (1992) Human thiopurine methyltransferase pharmacogenetics: biochemical properties, liver-erythrocyte correlation and presence of isoenzymes. Pharmacogenetics 2:148-159
31. Tinel M, Berson A, Pessayre D, Letteron P, Cattoni MP, Horsman Y, Larrey D (1991) Pharmacogenetics of human erythrocyte thiopurine methylation activity in a French population. Br J Clin Pharmacol 32:729-734
32. Van Loon J, Szumlanski CL, Weinshilboum EM (1992) Human kidney thiopurine methyltransferase photoaffinity labelling with S-adenosyl-L-methionine. Biochem Pharmacol 44:775-785
33. Van Loon J, Weinshilboum, RM (1990) Thiopurine methyltransferase isozymes in human renal tissue. Drug Metab Disp 18: 632-838
34. Weinshilboum RM, Raymond FA, Pazmino PA (1978) Human erythrocyte thiopurine methyltransferase: radiochemical microassay and biochemical properties. Clin Chim Acta 85:323-333
35. Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Genet: 32:651-662
36. Woodson L, Weinshilboum RM (1983) Human kidney thiopurine methyltransferase purification and biochemical properties. Biochem Pharmacol 32:819-826
37. Woodson LC, Dunnet JH, Weinshilboum RM (1982) Pharmacogenetics of human thiopurine methyltransferase: Kidney erythrocyte correlation and immunotitration studies. J Pharmacol Exp Ther 222:174-181